Cme (CME) Liabilities and Shareholders Equity (2009 - 2026)

Cme (CME) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $202.0 billion in Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $202.0 billion, up 27.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $767.5 billion (up 37.92% YoY), and the FY2025 annual result was $198.4 billion, up 44.36% from the prior year.
• Liabilities and Shareholders Equity advanced to $202.0 billion in Q1 2026 per CME's latest filing, from $198.4 billion in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $205.9 billion in Q1 2022 and troughed at $123.4 billion in Q2 2024.
• A 5-year average of $162.6 billion and a median of $166.0 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2023 and 2025: Liabilities and Shareholders Equity fell 29.61% in 2023, then jumped 45.82% in 2025.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $174.2 billion in 2022, then slipped by 25.53% to $129.7 billion in 2023, then climbed by 5.97% to $137.4 billion in 2024, then soared by 44.36% to $198.4 billion in 2025, then climbed by 1.8% to $202.0 billion in 2026.
• Business Quant data shows CME's Liabilities and Shareholders Equity at $202.0 billion in Q1 2026, $198.4 billion in Q4 2025, and $187.1 billion in Q3 2025.